Concepedia

Randomized, controlled trial of recombinant human interleukin‐11 in patients with active Crohn's disease

Bruce E. Sands, Barry Winston, Bruce Salzberg, Michael Safdi, Charles F. Barish, Lawrence D. Wruble, Robert A. Wilkins, Mark Shapiro, Ulrich Schwertschlag

Alimentary Pharmacology & Therapeutics · 2002 · 139 citations · 22 references

DOIFull text

Open access

Abstract

Weekly subcutaneous injection with rhIL-11 15 microg/kg is safe and effective in inducing remission in a subset of patients with active Crohn's disease.

References

22

Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study.

William R. Best, Jack M. Becktel, John W. Singleton et al. · PubMed · 1976 · 3.2K citations

A Short-Term Study of Chimeric Monoclonal Antibody cA2 to Tumor Necrosis Factor α for Crohn's Disease

Stephan R. Targan, Stephen B. Hanauer, Sander J. H. van Deventer et al. · New England Journal of Medicine · 1997 · 3.1K citations · Full text

Development of a Crohn's Disease Activity Index

William R. Best, Jack M. Becktel, John W. Singleton et al. · Gastroenterology · 1976 · 3.1K citations

, , +2

A New Measure of Health Status for Clinical Trials in Inflammatory Bowel Disease

Alba Mitchell, E. Jan Irvine, Joel Singer et al. · Gastroenterology · 1989 · 1.2K citations · Full text

, , +9

A new measure of health status for clinical trials in inflammatory bowel disease

Gordon Guyatt, Alba Mitchell, E. Jan Irvine et al. · Gastroenterology · 1989 · 732 citations · Full text

, , +9